Ehlers-Danlos Syndrome
|
0.050 |
Biomarker
|
disease |
BEFREE |
Nevo syndrome is allelic to the kyphoscoliotic type of the Ehlers-Danlos syndrome (EDS VIA).
|
15666309 |
2005 |
Congenital kyphoscoliosis
|
0.020 |
Biomarker
|
disease |
BEFREE |
We conclude that the Nevo syndrome is allelic to and clinically indistinguishable from EDS VIA, and present evidence that increased length at birth and wristdrop, in addition to muscular hypotonia and kyphoscoliosis, should prompt the physician to consider EDS VIA earlier than heretofore.
|
15666309 |
2005 |
Kyphoscoliosis deformity of spine
|
0.020 |
Biomarker
|
disease |
BEFREE |
We conclude that the Nevo syndrome is allelic to and clinically indistinguishable from EDS VIA, and present evidence that increased length at birth and wristdrop, in addition to muscular hypotonia and kyphoscoliosis, should prompt the physician to consider EDS VIA earlier than heretofore.
|
15666309 |
2005 |
Acquired Kyphoscoliosis
|
0.020 |
Biomarker
|
disease |
BEFREE |
We conclude that the Nevo syndrome is allelic to and clinically indistinguishable from EDS VIA, and present evidence that increased length at birth and wristdrop, in addition to muscular hypotonia and kyphoscoliosis, should prompt the physician to consider EDS VIA earlier than heretofore.
|
15666309 |
2005 |
Nevo syndrome (disorder)
|
0.010 |
Biomarker
|
disease |
BEFREE |
We conclude that the Nevo syndrome is allelic to and clinically indistinguishable from EDS VIA, and present evidence that increased length at birth and wristdrop, in addition to muscular hypotonia and kyphoscoliosis, should prompt the physician to consider EDS VIA earlier than heretofore.
|
15666309 |
2005 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Recombinant semaphorin 6A-1 ectodomain inhibits in vivo growth factor and tumor cell line-induced angiogenesis.
|
15917651 |
2005 |
Ehlers-Danlos Syndrome
|
0.050 |
GeneticVariation
|
disease |
BEFREE |
Mutation analysis of the PLOD1 gene: an efficient multistep approach to the molecular diagnosis of the kyphoscoliotic type of Ehlers-Danlos syndrome (EDS VIA).
|
15979919 |
2006 |
Connective Tissue Diseases
|
0.010 |
Biomarker
|
group |
BEFREE |
The kyphoscoliotic type of Ehlers-Danlos syndrome (EDS VIA) is an inheritable connective tissue disorder characterized by a deficiency of lysyl hydroxylase due to mutations in PLOD1.
|
15979919 |
2006 |
Histiocytosis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Of interest, SEMA6A protein was strongly expressed on skin and bone LCs and on LCs in draining lymph nodes from patients with LC histiocytosis or dermatopathic lymphadenitis, respectively, representing two inflammatory conditions in which LCs display an immature DC-LAMP(low), CD83(low), and CCR7+ phenotype.
|
16436660 |
2006 |
Histiocytosis
|
0.010 |
AlteredExpression
|
disease |
LHGDN |
Of interest, SEMA6A protein was strongly expressed on skin and bone LCs and on LCs in draining lymph nodes from patients with LC histiocytosis or dermatopathic lymphadenitis, respectively, representing two inflammatory conditions in which LCs display an immature DC-LAMP(low), CD83(low), and CCR7+ phenotype.
|
16436660 |
2006 |
Lymphadenitis
|
0.010 |
AlteredExpression
|
disease |
LHGDN |
Of interest, SEMA6A protein was strongly expressed on skin and bone LCs and on LCs in draining lymph nodes from patients with LC histiocytosis or dermatopathic lymphadenitis, respectively, representing two inflammatory conditions in which LCs display an immature DC-LAMP(low), CD83(low), and CCR7+ phenotype.
|
16436660 |
2006 |
Dermatopathic lymphadenitis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Of interest, SEMA6A protein was strongly expressed on skin and bone LCs and on LCs in draining lymph nodes from patients with LC histiocytosis or dermatopathic lymphadenitis, respectively, representing two inflammatory conditions in which LCs display an immature DC-LAMP(low), CD83(low), and CCR7+ phenotype.
|
16436660 |
2006 |
Histiocytic syndrome
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Of interest, SEMA6A protein was strongly expressed on skin and bone LCs and on LCs in draining lymph nodes from patients with LC histiocytosis or dermatopathic lymphadenitis, respectively, representing two inflammatory conditions in which LCs display an immature DC-LAMP(low), CD83(low), and CCR7+ phenotype.
|
16436660 |
2006 |
Colorectal Carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Comparative integromics on non-canonical WNT or planar cell polarity signaling molecules: transcriptional mechanism of PTK7 in colorectal cancer and that of SEMA6A in undifferentiated ES cells.
|
17671748 |
2007 |
Malignant neoplasm of colon and/or rectum
|
0.020 |
Biomarker
|
disease |
BEFREE |
Comparative integromics on non-canonical WNT or planar cell polarity signaling molecules: transcriptional mechanism of PTK7 in colorectal cancer and that of SEMA6A in undifferentiated ES cells.
|
17671748 |
2007 |
Gastrointestinal Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
PTK7 and SEMA6A were expressed in undifferentiated embryonic stem (ES) cells, SEMA6A in endodermal progenitors, CELSR1, VANGL1 and PTK7 in gastrointestinal tumors.
|
17671748 |
2007 |
insulinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
The group VIA calcium-independent phospholipase A2 participates in ER stress-induced INS-1 insulinoma cell apoptosis by promoting ceramide generation via hydrolysis of sphingomyelins by neutral sphingomyelinase.
|
17685585 |
2007 |
Glaucoma, Primary Open Angle
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Eight differentially expressed genes were located in known primary open-angle glaucoma (POAG) loci, including MYOC, SOAT1, CYP27A1, SPOCK, SEMA6A, EGR1, GAS1, and ATP10A.
|
18436822 |
2008 |
Crohn Disease
|
0.100 |
GeneticVariation
|
disease |
GWASDB |
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease.
|
18587394 |
2008 |
Cerebral Infarction
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
We conclude that semaphorin 6a overexpressed in the cortex enhances recovery after cerebral ischemia.
|
20505770 |
2010 |
Chronic cerebrovascular accident
|
0.010 |
Biomarker
|
disease |
BEFREE |
Semaphorin 6a may represent a novel therapeutic candidate for the treatment of chronic stroke.
|
20505770 |
2010 |
Congenital kyphoscoliosis
|
0.020 |
Biomarker
|
disease |
BEFREE |
The clinical findings of EDS kyphoscoliotic type (EDS type VIA and B) comprise kyphoscoliosis, muscular hypotonia, hyperextensible, thin and bruisable skin, atrophic scarring, joint hypermobility and variable ocular involvement.
|
20842734 |
2010 |
Kyphoscoliosis deformity of spine
|
0.020 |
Biomarker
|
disease |
BEFREE |
The clinical findings of EDS kyphoscoliotic type (EDS type VIA and B) comprise kyphoscoliosis, muscular hypotonia, hyperextensible, thin and bruisable skin, atrophic scarring, joint hypermobility and variable ocular involvement.
|
20842734 |
2010 |
Acquired Kyphoscoliosis
|
0.020 |
Biomarker
|
disease |
BEFREE |
The clinical findings of EDS kyphoscoliotic type (EDS type VIA and B) comprise kyphoscoliosis, muscular hypotonia, hyperextensible, thin and bruisable skin, atrophic scarring, joint hypermobility and variable ocular involvement.
|
20842734 |
2010 |
Ehlers-Danlos Syndrome
|
0.050 |
GeneticVariation
|
disease |
BEFREE |
Phenotypic variability of the kyphoscoliotic type of Ehlers-Danlos syndrome (EDS VIA): clinical, molecular and biochemical delineation.
|
21699693 |
2011 |